AR034950A1 - COMPOSITION OF VACCINE AGAINST BRUCELOSIS THAT INCLUDES POLY MICROPARTICLES OF POLY (E-CAPROLACTONE) AS AN ASSISTANT - Google Patents
COMPOSITION OF VACCINE AGAINST BRUCELOSIS THAT INCLUDES POLY MICROPARTICLES OF POLY (E-CAPROLACTONE) AS AN ASSISTANTInfo
- Publication number
- AR034950A1 AR034950A1 ARP020102898A ARP020102898A AR034950A1 AR 034950 A1 AR034950 A1 AR 034950A1 AR P020102898 A ARP020102898 A AR P020102898A AR P020102898 A ARP020102898 A AR P020102898A AR 034950 A1 AR034950 A1 AR 034950A1
- Authority
- AR
- Argentina
- Prior art keywords
- poly
- caprolactone
- microparticles
- brucelosis
- assistant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/098—Brucella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
La composición de vacuna subcelular comprende una sustancia inmunogénicamente activa frente a Brucella spp. y un adyuvante que comprende micropartículas de poli(e-caprolactona) que encapsulan a una mezcla dicha sustancia inmunogénicamente activa frente a Brucella spp. y distintos agentes complejantes y solubilizantes.The subcellular vaccine composition comprises an immunogenically active substance against Brucella spp. and an adjuvant comprising poly (e-caprolactone) microparticles that encapsulate said immunogenically active substance against Brucella spp. and different complexing and solubilizing agents.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200101801A ES2190350B1 (en) | 2001-07-31 | 2001-07-31 | COMPOSITION OF VACCINE AGAINST BRUCELOSIS THAT INCLUDES POLY MICROPARTICLES OF POLY (E-CAPROLACTONE) AS AN ASSISTANT. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR034950A1 true AR034950A1 (en) | 2004-03-24 |
Family
ID=8498592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020102898A AR034950A1 (en) | 2001-07-31 | 2002-07-31 | COMPOSITION OF VACCINE AGAINST BRUCELOSIS THAT INCLUDES POLY MICROPARTICLES OF POLY (E-CAPROLACTONE) AS AN ASSISTANT |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR034950A1 (en) |
AU (1) | AU2002365205A1 (en) |
ES (1) | ES2190350B1 (en) |
WO (1) | WO2003059383A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2327375B1 (en) | 2007-11-14 | 2010-08-05 | Universidad Del Pais Vasco | USE OF MICROPARTICLES FOR USE AS VACCINES AND THE RELEASE OF BIOLOGICALLY ACTIVE MOLECULES. |
AR073907A1 (en) * | 2009-10-19 | 2010-12-09 | Consejo Nac Invest Cient Tec | ADJUSTER FOR VACCINES, WHICH INCLUDES AN UNLIPPED POLIPEPTIDE FROM THE EXTERNAL MEMBRANE (OMP) OF BACTERIA, VACCINES THAT UNDERSTAND AND USES |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999061062A1 (en) * | 1998-05-29 | 1999-12-02 | Massachusetts Institute Of Technology | Cyclodextrin complexes |
-
2001
- 2001-07-31 ES ES200101801A patent/ES2190350B1/en not_active Expired - Lifetime
-
2002
- 2002-07-23 AU AU2002365205A patent/AU2002365205A1/en not_active Abandoned
- 2002-07-23 WO PCT/ES2002/000367 patent/WO2003059383A1/en not_active Application Discontinuation
- 2002-07-31 AR ARP020102898A patent/AR034950A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002365205A1 (en) | 2003-07-30 |
ES2190350B1 (en) | 2005-01-01 |
ES2190350A1 (en) | 2003-07-16 |
WO2003059383A1 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60134699D1 (en) | Electron-emitting device, electron source and image forming apparatus | |
NL1021816A1 (en) | Exposure method and exposure device. | |
DE60229468D1 (en) | Electron-emitting device, electron source and image forming apparatus | |
SG148031A1 (en) | Use of cci-779 as an antineoplastic agent | |
WO2004011984A3 (en) | Retainer, exposure apparatus, and semiconductor device fabrication method | |
DE60139532D1 (en) | Radiation source, lithography apparatus, device manufacturing method and device manufactured therewith | |
EP1273907A4 (en) | Wafer inspecting method, wafer inspecting instrument, and electron beam apparatus | |
EA201000491A1 (en) | AMINOMETHYLENE TESTING | |
TR200201443T2 (en) | Dry cleaning solvent and a method for using it | |
DE60231749D1 (en) | SUPER CHARGE MESSAGING DEVICE | |
EP2306528A3 (en) | Nitride semiconductor light emitting device and fabrication method thereof | |
NL1021853A1 (en) | Method for inspecting an exposure device, an exposure method for correcting a focal point, and a method for manufacturing a semiconductor device. | |
DE60143555D1 (en) | An electron source, display manufacturing apparatus and method therefor, and substrate processing apparatus and method therefor | |
DE60214771D1 (en) | BRAKING DEVICE, ARRANGEMENT AND PROCESS | |
ATE356357T1 (en) | PROSTATE CANCER MARKERS | |
CL2007003010A1 (en) | Oral dosage form comprising an erodible core that contains an active principle of a weak basic character, an erodible coating around said core with one or more openings that pass through the coating and connect the core with the means of use; preparation procedure; and use (divisional of 260-03). | |
FI20011601A0 (en) | Irradiation control in an X-ray imaging device used for intraoral application | |
DE60237143D1 (en) | RECEIVING DEVICE, RECEIVING METHOD AND NAME RESOLUTION METHOD | |
DE50308309D1 (en) | Beam guiding system, imaging method and electron microscopy system | |
AR033012A1 (en) | ANTINEOPLASIC COMBINATIONS | |
AR034950A1 (en) | COMPOSITION OF VACCINE AGAINST BRUCELOSIS THAT INCLUDES POLY MICROPARTICLES OF POLY (E-CAPROLACTONE) AS AN ASSISTANT | |
ITTO20000871A0 (en) | PROCEDURE AND DEVICE FOR GENERATION OF CODES, FOR EXAMPLE CODES FOR CDMA APPLICATIONS. | |
DE60202919D1 (en) | Receiving unit, receiving method and semiconductor device | |
CO5660272A2 (en) | BOVINE VACCINES WITH ASSISTANTS | |
GB0123771D0 (en) | Semiconductor device manufacturing system and electron beam exposure apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |